I hope you are well.
As you previously attended an FT healthcare event I wanted to reach out and highlight the FT Global Pharma and Biotech Summit. Taking place from 07-09 November we will return in-person to the Royal Lancaster in London, gathering CEOs, policymakers and thought leaders from the industry.
Secure your place here.
Join us again this year to learn about new frontiers for business and healthcare, networking with senior exceutives and discuss key topics including:
- Where are investors in life sciences putting their money?
- How can data science be applied at the molecular level?
- Will cell and gene therapies transform healthcare for millions or a select few?
- Pricing and market access - What to expect in 2023
Sneak preview of the companies already registered to attend:
AstraZeneca, Astellas, Amcor, Bayer, Bain & Company, Baseimmune, Biogen, Boehringer Ingelheim, Deloitte, Eli Lilly, GHO Capital Partners, GlobalData, GSK, Johnson & Johnson, Latham & Watkins, Linklaters, London Business School, NHS, Pfizer, Roche,Sandoz, Sanofi, Syneos Health, Thermo Fisher Scientific, UCL, and many more.
Next week we will be launching our event and networking app - Brella. Which will allow registered attendees to see who’s attending, create your own personal agenda and schedule one-to-one meetings.
If you would like to find out more about the event or speak with me directly please email me, or call me on the details below.Regards,
Client Liason Manager
T: +44 (0)20 7873 4959
Financial Times Live | Global Conferences & Events
Bracken House, 1 Friday Street, London, EC4M 9BT